First Round of Abstract Submission Ends: Jan 15, 2024
Extended Early Bird Ends: Jan 28, 2024

Keynote Speakers

Prof. Gregory Lanzaro
University of California at Davis, USA
Title: Will update soon
Professor Gregory Lanzaro is a medical entomologist with an interest in vector population genetics and genomics. He received his Ph.D. in entomology from the University of Florida and went on to work on a MacArthur Fellowship at the Laboratory of Malaria Research, National Institutes of Health, USA. After leaving the NIH he served as Professor in the Center for Tropical Diseases at the University of Texas Medical Branch. He is currently Professor in the Department of Pathology, Microbiology, and Immunology at the University of California at Davis. Doctor Lanzaro has over thirty years’ experience working on the genetics of malaria vectors across sub-Saharan Africa. He now serves as the Director of the UC Davis Vector Genetics Laboratory and Principal Investigator of the University of California Malaria Initiative on the Davis campus.
Dr. Sinéad C. Corr
University College Cork, Ireland
Title: Will be updated soon
Sinéad Corr received her BSc degree and PhD in Molecular Microbiology from University College Cork. During this time she investigated the interaction of the food borne pathogen Listeria monocytogenes with the gastrointestinal epithelium and the therapeutic potential of probiotics to treat infection. This was followed by postdoctorate work as part of a collaboration between GlaxoSmithKline and the APC Microbiome Ireland investigating novel therapeutics for the treatment of IBD, and subsequently at the School of Biochemistry and Immunology, Trinity College Dublin (TCD) investigating the role of innate signalling pathways in regulation of intestinal defences. In 2015, Sinéad was appointed Assistant Professor at the Dept. of Microbiology, Trinity College Dublin and joined the School of Microbiology and APC Microbiome Ireland, University College Cork as Senior Lecturer in Microbiome Sciences in 2024. Sinéad leads the Microbiome & Mucosal Immunity research group where research interests include deciphering the molecular mechanisms underpinning interactions between the gut microbiome and the gut mucosal barrier. The subsequent maintenance of health or development of infectious or inflammatory disease as a result of this interplay is of particular interest. Of particular interest is the Identification of therapeutic strategies including novel dietary interventions, postbiotics and naturally-sourced bio-actives to manipulate intestinal immunity or target pathogenic bacteria and enhance the beneficial aspects of the gut microbiome, with the ultimate goal of boosting gut health and reducing the severity of intestinal infectious and inflammatory diseases.
Prof. Katia Denise Saraiva Bresciani
São Paulo State University (UNESP), Brazil
Title: Will update soon
Graduated in Veterinary Medicine at Unesp, Botucatu, São Paulo, Brasil. Master’s degree in Animal Pathology and Doctor’s degree in Preventive Veterinary Medicine at Unesp, Jaboticabal, SP, Brasil. Post-Doctoral degree in Parasitology and Scientific Writing at Unesp, Botucatu, SP, Brasil; Post-Doctoral degree in Scientific Writing at Universidade de Lisboa, Portugal. Associated Professor, Parasitic Diseases of Animals is working at Unesp, Araçatuba, SP, Brasil.

Principal Investigator of a Universal Project of the National Council of Scientific and Technological Development (CNPq), Brazil. Editor of three international books: “Main Canine Protozoan Zoonosis”, “Major Zoonosis by Helminths and Ectoparasites in Dogs” and “Main Canine Parasitic Zoonosis” and two international books: “Cryptosporidiosis in Human and Domestic Animals” by Nova Science Publishers, New York, United States of America. Advisor of 20 Master’s dissertation, 20 Doctor’s thesis and several Scientific Initiation works. Author and/or co-author in 190 papers in specialized journals, 516 abstracts of scientific works in conference proceedings and 94 book chapters. Awarded with eight prizes or homages.
Dr. Sergey Iordanskiy
Uniformed Services University of the Health Sciences, USA
Title: Will be update soon
Over the past twenty years, the major focus of Sergey Iordanskiy’s research has been the molecular mechanisms of retroviral replication and various aspects of innate immunity in the context of viral expression and latency. Currently, Dr. Iordanskiy is a faculty member and principal investigator in the Department of Pharmacology and Molecular Therapeutics at Uniformed Services University of the Health Science in Bethesda, Maryland, USA. He is also an Adjunct Assistant Professor at George Washington University in Washington, District of Columbia. While he has worked for many years with HIV, a major interest of his laboratory has recently become the role of endogenous retroviruses (more than 8% of the human genome) in regulating myeloid cell differentiation and the innate immune response to various stressors and infections. Specifically, Iordanskiy’s group in collaboration with colleagues from the National Institutes of Health, elucidated the impact of human endogenous retroviruses on the immune phenotype of macrophages upon the pressure of damage- and pathogen-associated molecular patterns. Particular retroviral loci have been identified as essential modulators of interferon activity and cytokine profiles in health and disease. Another focus of Iordanskiy's research is radiation immunopathogenesis. Previously, he investigated the effect of ionizing radiation on the activation of sense and anti-sense transcription of retroviruses, including HIV-1. His group later identified a dose-dependent switch of signaling pathways mediated by intracellular pattern recognition receptors (PRRs) in response to increasing radiation doses in the context of radiation therapy, radiation-related cell damage, and pro-/anti-tumor differentiation of macrophages. A particular ratio of cytoplasmic nucleic acid substrates determines the activation of PRR signaling pathways (such as MAVS, STING, TLR3/7/8), which are responsible for the pro-inflammatory shift in the phenotype of myeloid cells. Dr. Iordanskiy serves on the scientific review boards and editorial boards of Frontiers in Virology, Open Virology, and Viruses, and is a mentor to graduate students and postdocs.